SG/CALL/ABBOTT LABORATORIES/100/0.1/21.06.24 Share Price

Warrant

DE000SQ0VUS5

Delayed Deutsche Boerse AG 20:23:05 23/05/2024 BST
0.51 EUR -5.56% Intraday chart for SG/CALL/ABBOTT LABORATORIES/100/0.1/21.06.24
Current month-28.00%
1 month-37.21%
Date Price Change
23/05/24 0.51 -5.56%
22/05/24 0.54 +31.71%
21/05/24 0.41 -8.89%
20/05/24 0.45 -10.00%
17/05/24 0.5 -10.71%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 08:23 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ0VUS
ISINDE000SQ0VUS5
Date issued 23/09/2022
Strike 100 $
Maturity 21/06/2024 (29 Days)
Parity 10 : 1
Emission price 1.86
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.43
Lowest since issue 0.37
Delta0.78x
Omega 14.97
Premium1.19x
Gearing19.1x
Moneyness 1.042
Difference Strike -4.295 $
Difference Strike %-4.30%
Spread 0.01
Spread %1.96%
Intrinsic value 0.3850

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8 USD
Average target price
125.7 USD
Spread / Average Target
+19.91%
Consensus